TEAS Plus New Application

AREXVY

GlaxoSmithKline Biologicals SA

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97052261
Filing Date: 09/29/2021

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK AREXVY
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT AREXVY
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK GlaxoSmithKline Biologicals SA
*MAILING ADDRESS Rue de l'Institut 89
*CITY Rixensart
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Belgium
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
B-1330
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
*TYPE private company limited by shares (prc)
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Belgium
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
*FILING BASIS SECTION 1(b)
*FILING BASIS SECTION 44(d)
       *FOREIGN APPLICATION NUMBER 3662314
       *FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United Kingdom
       *FOREIGN FILING DATE 06/30/2021
       INTENT TO
       PERFECT 44(d)
At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis for registration, but is only asserting a valid claim of priority.
ADDITIONAL STATEMENTS SECTION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
 
SIGNIFICANCE OF MARK The word(s) AREXVY has no meaning in a foreign language.
ATTORNEY INFORMATION
NAME Christopher M. Hanes
ATTORNEY DOCKET NUMBER 84025198
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME GSK
INTERNAL ADDRESS 5.5A, LBP
STREET 5 Moore Drive
CITY Research Triangle Park
STATE North Carolina
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 27709
PHONE 919-450-7041
FAX 919-315-3023
EMAIL ADDRESS trademarks@gsk.com
OTHER APPOINTED ATTORNEY Arrielle S. Millstein
CORRESPONDENCE INFORMATION
NAME Christopher M. Hanes
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@gsk.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /Christopher M. Hanes/
* SIGNATORY'S NAME Christopher M. Hanes
* SIGNATORY'S POSITION Trademark Counsel, NC bar member
SIGNATORY'S PHONE NUMBER 919-450-7041
* DATE SIGNED 09/29/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97052261
Filing Date: 09/29/2021

To the Commissioner for Trademarks:

MARK: AREXVY (Standard Characters, see mark)
The literal element of the mark consists of AREXVY. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, GlaxoSmithKline Biologicals SA, a private company limited by shares (prc) legally organized under the laws of Belgium, having an address of
      Rue de l'Institut 89
      Rixensart B-1330
      Belgium
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on United Kingdom application number 3662314, filed 06/30/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant has another basis for registration (Section 1(a) or Section 1(b)) and does NOT intend to rely on Section 44(e) as the basis for registration, but is only asserting a valid claim of priority.



Significance of wording, letter(s), or numeral(s)
The word(s) AREXVY has no meaning in a foreign language.


The owner's/holder's proposed attorney information: Christopher M. Hanes. Other appointed attorneys are Arrielle S. Millstein. Christopher M. Hanes of GSK, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      5.5A, LBP
      5 Moore Drive
      Research Triangle Park, North Carolina 27709
      United States
      919-450-7041(phone)
      919-315-3023(fax)
      trademarks@gsk.com
The docket/reference number is 84025198.
Christopher M. Hanes submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Christopher M. Hanes
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gsk.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Christopher M. Hanes/   Date: 09/29/2021
Signatory's Name: Christopher M. Hanes
Signatory's Position: Trademark Counsel, NC bar member
Signatory's Phone Number: 919-450-7041
Signature method: Sent to third party for signature
Payment Sale Number: 97052261
Payment Accounting Date: 09/29/2021

Serial Number: 97052261
Internet Transmission Date: Wed Sep 29 16:49:17 ET 2021
TEAS Stamp: USPTO/FTK-XXX.XX.XX.X-202109291649173138
12-97052261-7817b1c7fcda5e5bf30c7e1e28fb
f56ae55f1cb9f5efb9b3eafdf443621838ebe-DA
-49171446-20210928155703498348

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed